Latest & greatest articles for osteoporosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on osteoporosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on osteoporosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for osteoporosis

21. Acupuncture and moxibustion for primary osteoporosis: an overview of systematic reviews

Acupuncture and moxibustion for primary osteoporosis: an overview of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

22. Prevalence of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: a systematic review and meta-analysis

Prevalence of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

23. The potential of Labisia pumila for the treatment of post-menopausal osteoporosis

The potential of Labisia pumila for the treatment of post-menopausal osteoporosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

24. Specificity of cone-beam computed tomography in the diagnosis of osteoporosis in postmenopausal women: systematic review

Specificity of cone-beam computed tomography in the diagnosis of osteoporosis in postmenopausal women: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

25. Bisphosphonates for older adults with primary osteopenia or osteoporosis: a bayesian network meta-analysis

Bisphosphonates for older adults with primary osteopenia or osteoporosis: a bayesian network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

26. Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

27. The efficiency and safety of teriparatide versus alendronate for the treatment of postmenopausal osteoporosis: a meta-analysis of randomized controlled trials in China

The efficiency and safety of teriparatide versus alendronate for the treatment of postmenopausal osteoporosis: a meta-analysis of randomized controlled trials in China Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

28. Effect of Pulsed Electromagnetic Field on bone related outcomes in experimental rodents of Osteoporosis : a systematic review

Effect of Pulsed Electromagnetic Field on bone related outcomes in experimental rodents of Osteoporosis : a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

29. Liuwei dihuang decoction for primary osteoporosis: a protocol for a systematic review and meta-analysis

Liuwei dihuang decoction for primary osteoporosis: a protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

30. Improving osteoporosis testing and treatment after fragility fracture: a systematic review

Improving osteoporosis testing and treatment after fragility fracture: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

31. Association between denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: a meta-analysis of randomized clinical trials

Association between denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: a meta-analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

32. Bone-building and antiresorptive agents in combination for osteoporosis in postmenopausal women: a network meta-analysis

Bone-building and antiresorptive agents in combination for osteoporosis in postmenopausal women: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

33. Effects of green tea consumption on postmenopausal osteoporosis: a systematic review and meta-analysis.

Effects of green tea consumption on postmenopausal osteoporosis: a systematic review and meta-analysis. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

34. Kidney stones and risk of osteoporosis and bone fracture

Kidney stones and risk of osteoporosis and bone fracture Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

35. Sequential therapy for postmenopausal osteoporosis: a network meta-analysis

Sequential therapy for postmenopausal osteoporosis: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

36. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta-analysis

Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

37. Efficacy of combination therapy of anabolic agents and bisphophonates compared to bisphosphonates alone on bone mineral density and fracture risk in post menopausal osteoporosis: a meta-analysis of randomized controlled trials

Efficacy of combination therapy of anabolic agents and bisphophonates compared to bisphosphonates alone on bone mineral density and fracture risk in post menopausal osteoporosis: a meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

38. Fracture risk reduction by anti-osteoporosis pharmacotherapy according to baseline fracture risk among post-menopausal women (protocol for a systematic review and meta-analysis of randomised trials)

Fracture risk reduction by anti-osteoporosis pharmacotherapy according to baseline fracture risk among post-menopausal women (protocol for a systematic review and meta-analysis of randomised trials) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

39. Moxibustion in primary osteoporosis: a systematic review and meta-analysis

Moxibustion in primary osteoporosis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

40. Acupuncture for postmenopausal osteoporosis: a systematic review protocol

Acupuncture for postmenopausal osteoporosis: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO